A Response to the Letter to the Editor: Comment on "Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRAS(G12C)-Mutated NSCLC Treated With Sotorasib".
Sophie M ErnstJan H von der ThüsenHendrikus J DubbinkAnne-Marie C DingemansPublished in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (2024)